Talk:Rucaparib
Appearance
This is the talk page for discussing improvements to the Rucaparib article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Rucaparib.
|
What mechanism and benefit
[edit]Presumably it could reduce the local spreading and lower the rate or risk of metastasis. - Any refs ? - Rod57 (talk) 11:07, 30 August 2014 (UTC)
Also inhibits PARP2 and PARP3
[edit][1] says "Rucaparib is an oral, small molecule inhibitor of PARP1, PARP2 and PARP3" - but need RS - Rod57 (talk) 19:02, 9 September 2017 (UTC)